QR Code

Towards a New Dawn for Neuro-Oncology: Nanomedicine at the Service of Drug Delivery for Primary and Secondary Brain Tumours

(1) Background/Objectives: Primary and secondary brain tumours often hold devastating prognoses and low survival rates despite the application of maximal neurosurgical resection, and state-of-the-art radiotherapy and chemotherapy. One limiting factor in their management is that several antineoplasti...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Smita Khilar, Antonina Dembinska-Kenner, Helen Hall, Nikolaos Syrmos, Gianfranco K. I. Ligarotti, Puneet Plaha, Vasileios Apostolopoulos, Salvatore Chibbaro, Giuseppe Maria Vincenzo Barbagallo, Mario Ganau
Hōputu: Artigo
Reo:Inglês
I whakaputaina: MDPI AG 2025-01-01
Rangatū:Brain Sciences
Ngā marau:
brain tumours
gliomas
glioblastoma
meningioma
brain metastases
malignant melanoma
Urunga tuihono:https://www.mdpi.com/2076-3425/15/2/136
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite